Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for KRYS

Stock NameKrystal Biotech Inc
TickerKRYS(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS5011471027
LEI549300YONUY68210OE41

Show aggregate KRYS holdings

News associated with KRYS

HC Wainwright Reaffirms Buy Rating for Krystal Biotech (NASDAQ:KRYS)
Krystal Biotech (NASDAQ:KRYS – Get Free Report)‘s stock had its “buy” rating reissued by HC Wainwright in a research report issued on Monday,Benzinga reports. They presently have a $240.00 target price on the stock. HC Wainwright’s target price suggests a potential upside of 55.46% from the company’s current price. Several other research firms have also […] - 2025-09-17 02:56:43
Krystal Biotech, Inc. (NASDAQ:KRYS) Receives $210.38 Average PT from Analysts
Shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the seven research firms that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average […] - 2025-09-11 02:46:50
Chardan Capital Lowers Krystal Biotech (NASDAQ:KRYS) Price Target to $216.00
Krystal Biotech (NASDAQ:KRYS – Free Report) had its price objective trimmed by Chardan Capital from $219.00 to $216.00 in a research note issued to investors on Friday,Benzinga reports. The firm currently has a buy rating on the stock. Several other research analysts have also issued reports on KRYS. Citigroup reiterated a “neutral” rating and set […] - 2025-08-25 02:58:58
PNC Financial Services Group Inc. Grows Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)
PNC Financial Services Group Inc. grew its stake in Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 27.4% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 2,141 shares of the company’s stock after acquiring an additional 461 shares during the period. PNC Financial Services Group Inc.’s […] - 2025-08-15 04:48:55
Krystal Biotech (NASDAQ:KRYS) Receives “Neutral” Rating from Citigroup
Krystal Biotech (NASDAQ:KRYS – Get Free Report)‘s stock had its “neutral” rating reiterated by equities researchers at Citigroup in a research note issued to investors on Tuesday, MarketBeat Ratings reports. They presently have a $166.00 price objective on the stock, down from their previous price objective of $176.00. Citigroup’s price target would indicate a potential […] - 2025-08-07 04:30:49
Federated Hermes Inc. Reduces Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS)
Federated Hermes Inc. lowered its stake in Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 2.0% during the 1st quarter, HoldingsChannel reports. The firm owned 12,781 shares of the company’s stock after selling 267 shares during the period. Federated Hermes Inc.’s holdings in Krystal Biotech were worth $2,304,000 as of its most recent filing with […] - 2025-08-06 06:28:56
Analysts Expect IJR Will Reach $131
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-05 07:38:03
Zurcher Kantonalbank Zurich Cantonalbank Has $1.04 Million Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS)
Zurcher Kantonalbank Zurich Cantonalbank lowered its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 5.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,742 shares of the company’s stock after selling 312 shares during the period. […] - 2025-08-05 05:06:52
Krystal Biotech (NASDAQ:KRYS) Sees Strong Trading Volume Following Strong Earnings
Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) saw strong trading volume on Monday after the company announced better than expected quarterly earnings. 279,432 shares traded hands during mid-day trading, a decline of 13% from the previous session’s volume of 319,447 shares.The stock last traded at $136.42 and had previously closed at $156.98. The company […] - 2025-08-05 02:20:51
Krystal Biotech Announces Approval Of VYJUVEK In Japan
(RTTNews) - Krystal Biotech (KRYS) announced that Japan's Ministry of Health, Labour and Welfare granted marketing authorization to VYJUVEK for the treatment of wounds in patients with dystrophic epidermolysis bullosa, starting from birth. VYJUVEK is the first genetic medicine ap - 2025-07-25 10:21:36
Teacher Retirement System of Texas Sells 578 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)
Teacher Retirement System of Texas cut its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 9.1% during the 1st quarter, HoldingsChannel.com reports. The fund owned 5,805 shares of the company’s stock after selling 578 shares during the period. Teacher Retirement System of Texas’ holdings in Krystal Biotech were worth $1,047,000 at […] - 2025-07-14 04:46:50
Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by Allspring Global Investments Holdings LLC
Allspring Global Investments Holdings LLC trimmed its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 82.6% during the first quarter, Holdings Channel reports. The institutional investor owned 5,180 shares of the company’s stock after selling 24,597 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Krystal Biotech were worth […] - 2025-07-09 04:42:14
Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Acquired by New York State Teachers Retirement System
New York State Teachers Retirement System increased its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 0.6% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 15,979 shares of the company’s stock after purchasing an additional 100 shares during the […] - 2025-07-08 05:21:00
Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by Illinois Municipal Retirement Fund
Illinois Municipal Retirement Fund cut its position in Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 9.8% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 12,762 shares of the company’s stock after selling 1,384 shares during the quarter. Illinois Municipal Retirement […] - 2025-06-30 05:14:49
Krystal Biotech, Inc. (NASDAQ:KRYS) Stock Position Lifted by GAMMA Investing LLC
GAMMA Investing LLC boosted its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 50,249.4% during the first quarter, HoldingsChannel.com reports. The firm owned 121,342 shares of the company’s stock after acquiring an additional 121,101 shares during the period. GAMMA Investing LLC’s holdings in Krystal Biotech were worth $21,878,000 as of its […] - 2025-06-06 06:16:55
Janus Henderson Group PLC Grows Position in Krystal Biotech, Inc. (NASDAQ:KRYS)
Janus Henderson Group PLC raised its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 16.1% during the fourth quarter, HoldingsChannel reports. The firm owned 10,071 shares of the company’s stock after purchasing an additional 1,400 shares during the quarter. Janus Henderson Group PLC’s holdings in Krystal Biotech were worth $1,579,000 as […] - 2025-05-23 05:19:08
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $2.39 Million Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. trimmed its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 1.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,205 shares of the company’s stock after selling 181 shares during the period. […] - 2025-05-22 06:30:46
Deutsche Bank AG Has $3.97 Million Stock Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)
Deutsche Bank AG boosted its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 62.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 25,361 shares of the company’s stock after acquiring an additional 9,750 shares during the quarter. Deutsche […] - 2025-05-20 05:14:53
Citigroup Has Lowered Expectations for Krystal Biotech (NASDAQ:KRYS) Stock Price
Krystal Biotech (NASDAQ:KRYS – Free Report) had its target price decreased by Citigroup from $215.00 to $155.00 in a research note published on Friday morning,Benzinga reports. Citigroup currently has a neutral rating on the stock. A number of other brokerages have also recently issued reports on KRYS. HC Wainwright reissued a “buy” rating and issued […] - 2025-05-19 02:46:51
Krystal Biotech (NASDAQ:KRYS) Hits New 52-Week Low on Disappointing Earnings
Shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) hit a new 52-week low during trading on Tuesday following a weaker than expected earnings announcement. The company traded as low as $137.00 and last traded at $139.47, with a volume of 283299 shares traded. The stock had previously closed at $162.29. The company reported […] - 2025-05-08 02:24:46
Tuesday's ETF Movers: TAN, XBI
In trading on Tuesday, the Invesco Solar ETF is outperforming other ETFs, up about 3.2% on the day. Components of that ETF showing particular strength include shares of Shoals Technologies Group, up about 19.8% and shares of Solaredge Technologies, up about 16.3% on the day. A - 2025-05-06 13:09:13
Commit To Purchase Krystal Biotech At $150, Earn 16.3% Annualized Using Options
Investors considering a purchase of Krystal Biotech Inc (Symbol: KRYS) stock, but cautious about paying the going market price of $169.11/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in parti - 2025-04-30 12:44:33
102,061 Shares in Krystal Biotech, Inc. (NASDAQ:KRYS) Purchased by Raymond James Financial Inc.
Raymond James Financial Inc. purchased a new position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 102,061 shares of the company’s stock, valued at approximately $15,989,000. Raymond James Financial Inc. owned approximately 0.35% […] - 2025-04-22 05:45:14
Bank of Montreal Can Increases Stake in Krystal Biotech, Inc. (NASDAQ:KRYS)
Bank of Montreal Can grew its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 5.7% in the fourth quarter, Holdings Channel.com reports. The firm owned 3,325 shares of the company’s stock after buying an additional 179 shares during the period. Bank of Montreal Can’s holdings in Krystal Biotech were worth $521,000 […] - 2025-04-22 04:50:52
Krystal Biotech, Inc. (NASDAQ:KRYS) Position Reduced by Invesco Ltd.
Invesco Ltd. reduced its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 24.7% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 275,195 shares of the company’s stock after selling 90,356 shares during the quarter. Invesco Ltd. owned about […] - 2025-04-17 05:57:00
Federated Hermes Inc. Has $2.04 Million Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS)
Federated Hermes Inc. raised its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 1.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 13,048 shares of the company’s stock after purchasing an additional 229 shares during the […] - 2025-04-14 06:20:51
Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Acquired by JPMorgan Chase & Co.
JPMorgan Chase & Co. boosted its position in Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 18.7% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 151,835 shares of the company’s stock after buying an additional 23,934 shares during the period. JPMorgan Chase & Co.’s holdings in Krystal Biotech were worth $23,786,000 as of […] - 2025-04-10 05:07:14
Mitsubishi UFJ Asset Management Co. Ltd. Cuts Position in Krystal Biotech, Inc. (NASDAQ:KRYS)
Mitsubishi UFJ Asset Management Co. Ltd. decreased its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 13.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,367 shares of the company’s stock after selling 210 shares during the period. Mitsubishi UFJ […] - 2025-04-04 05:12:57
Sei Investments Co. Sells 13,085 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)
Sei Investments Co. cut its position in Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 38.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 21,164 shares of the company’s stock after selling 13,085 shares during the quarter. Sei Investments Co.’s holdings in Krystal […] - 2025-04-04 04:38:46
4,300 Shares in Krystal Biotech, Inc. (NASDAQ:KRYS) Bought by KLP Kapitalforvaltning AS
KLP Kapitalforvaltning AS acquired a new stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,300 shares of the company’s stock, valued at approximately $674,000. Other institutional investors also […] - 2025-04-02 05:12:54

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc KRYS holdings

DateNumber of KRYS Shares HeldBase Market Value of KRYS SharesLocal Market Value of KRYS SharesChange in KRYS Shares HeldChange in KRYS Base ValueCurrent Price per KRYS Share HeldPrevious Price per KRYS Share Held
2025-09-26 (Friday)2,425USD 406,964USD 406,964
2025-09-25 (Thursday)2,425USD 390,789KRYS holding decreased by -2061USD 390,7890USD -2,061 USD 161.15 USD 162
2025-09-24 (Wednesday)2,425USD 392,850USD 392,850
2025-09-17 (Wednesday)2,409USD 371,106KRYS holding decreased by -795USD 371,1060USD -795 USD 154.05 USD 154.38
2025-09-16 (Tuesday)2,409USD 371,901USD 371,901
2025-09-12 (Friday)2,393USD 343,826USD 343,826
2025-09-11 (Thursday)2,393USD 345,453USD 345,453
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of KRYS by Blackrock for IE00B3VWM098

Show aggregate share trades of KRYS

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-08-21SELL-8 145.700* 161.30 Profit of 1,290 on sale
2025-07-31BUY24 153.870* 161.44
2025-06-30SELL-16 137.460* 163.34 Profit of 2,613 on sale
2025-06-25SELL-8 142.500* 163.80 Profit of 1,310 on sale
2025-06-20SELL-16 132.460* 164.35 Profit of 2,630 on sale
2025-05-23BUY8 125.050* 169.84
2025-05-19SELL-8 132.290* 171.25 Profit of 1,370 on sale
2025-05-15SELL-24 130.330* 171.97 Profit of 4,127 on sale
2025-05-12SELL-8 139.430* 172.97 Profit of 1,384 on sale
2025-05-09SELL-8 132.180* 173.34 Profit of 1,387 on sale
2025-04-30SELL-8 169.880* 174.66 Profit of 1,397 on sale
2025-04-24SELL-16 169.120* 174.87 Profit of 2,798 on sale
2025-04-17SELL-8 168.570* 175.30 Profit of 1,402 on sale
2025-04-15SELL-24 169.130* 175.48 Profit of 4,212 on sale
2025-04-14SELL-24 168.910* 175.56 Profit of 4,213 on sale
2025-04-09SELL-32 168.160* 175.93 Profit of 5,630 on sale
2025-04-07SELL-56 166.010* 176.25 Profit of 9,870 on sale
2025-04-04SELL-80 171.300* 176.30 Profit of 14,104 on sale
2025-03-31BUY8 180.300* 176.22
2025-03-19SELL-16 189.180* 174.93 Profit of 2,799 on sale
2025-03-14SELL-48 179.380* 174.50 Profit of 8,376 on sale
2025-03-13SELL-16 177.370* 174.46 Profit of 2,791 on sale
2025-03-12SELL-272 178.390* 174.41 Profit of 47,438 on sale
2025-03-07SELL-16 179.935* 174.02 Profit of 2,784 on sale
2025-03-06SELL-24 178.930* 173.95 Profit of 4,175 on sale
2025-03-03SELL-8 171.830* 173.86 Profit of 1,391 on sale
2025-02-28SELL-48 179.250* 173.77 Profit of 8,341 on sale
2025-02-26SELL-8 176.390* 173.74 Profit of 1,390 on sale
2025-02-25SELL-24 181.100* 173.61 Profit of 4,167 on sale
2025-02-18BUY40 156.690* 173.19
2025-02-13BUY8 155.750* 174.34
2025-02-12BUY8 151.320* 174.81
2025-02-11BUY24 149.920* 175.33
2025-02-06BUY72 161.060* 176.56
2025-01-27BUY8 159.060* 180.32
2024-12-30BUY40 159.800* 183.21
2024-12-06BUY32 185.250* 183.02
2024-12-05BUY8 179.760* 183.13
2024-12-04BUY40 187.620* 182.97
2024-11-29BUY40 197.420* 181.79
2024-11-27BUY32 196.910* 180.48
2024-11-26BUY8 196.520* 179.75
2024-11-21BUY40 182.290* 178.27
2024-11-20BUY24 178.100* 178.28
2024-11-18BUY96 175.640* 178.47
2024-11-12BUY64 187.220* 177.89
2024-11-08BUY40 199.610* 176.34
2024-11-07BUY120 185.450* 175.64
2024-11-06BUY16 183.090* 175.02
2024-10-31BUY8 172.530* 175.76
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of KRYS

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19183,2920271,34167.6%
2025-09-1850,43619114,04844.2%
2025-09-1774,9670107,12970.0%
2025-09-16111,19931139,38079.8%
2025-09-15250,16125382,14465.5%
2025-09-12137,7890166,73982.6%
2025-09-11108,35830141,65476.5%
2025-09-10121,1670148,92681.4%
2025-09-09101,6160145,89169.7%
2025-09-08116,6930127,51291.5%
2025-09-0522,0380116,69318.9%
2025-09-0449,719094,46052.6%
2025-09-0354,097098,90154.7%
2025-09-0263,004086,34173.0%
2025-08-2931,697073,03343.4%
2025-08-2843,753080,48254.4%
2025-08-2741,556055,18975.3%
2025-08-2652,461073,51671.4%
2025-08-2549,670071,65469.3%
2025-08-2245,270063,83670.9%
2025-08-2146,454064,46072.1%
2025-08-2048,711064,36475.7%
2025-08-1929,185045,13964.7%
2025-08-1872,672093,02278.1%
2025-08-1546,244061,67675.0%
2025-08-1493,0200135,75468.5%
2025-08-1381,3720123,49165.9%
2025-08-1262,081081,20976.4%
2025-08-1161,4270111,39055.1%
2025-08-0866,6580143,46646.5%
2025-08-0769,8980103,95967.2%
2025-08-0675,1370153,98548.8%
2025-08-05127,4038,526196,36464.9%
2025-08-04487,4636,132712,72368.4%
2025-08-01144,4960222,65464.9%
2025-07-3174,0460105,57070.1%
2025-07-3064,909089,62572.4%
2025-07-2950,8117867,29275.5%
2025-07-28103,50212,661152,34867.9%
2025-07-2584,5902136,78361.8%
2025-07-2463,08133872,55386.9%
2025-07-2391,8150103,32888.9%
2025-07-2271,15645286,09182.7%
2025-07-2152,9425163,22183.7%
2025-07-1871,64710296,52074.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.